These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12204791)

  • 1. Effect of gemfibrozil on apolipoprotein B secretion and diacylglycerol acyltransferase activity in human hepatoblastoma (HepG2) cells.
    Zhu D; Ganji SH; Kamanna VS; Kashyap ML
    Atherosclerosis; 2002 Oct; 164(2):221-8. PubMed ID: 12204791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory activity of diacylglycerol acyltransferase (DGAT) and microsomal triglyceride transfer protein (MTP) by the flavonoid, taxifolin, in HepG2 cells: potential role in the regulation of apolipoprotein B secretion.
    Casaschi A; Rubio BK; Maiyoh GK; Theriault AG
    Atherosclerosis; 2004 Oct; 176(2):247-53. PubMed ID: 15380446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of fatty acids on apolipoprotein B secretion by human hepatoma cells (HEP G2).
    Arrol S; Mackness MI; Durrington PN
    Atherosclerosis; 2000 Jun; 150(2):255-64. PubMed ID: 10856517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Niacin accelerates intracellular ApoB degradation by inhibiting triacylglycerol synthesis in human hepatoblastoma (HepG2) cells.
    Jin FY; Kamanna VS; Kashyap ML
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1051-9. PubMed ID: 10195935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chalcone xanthohumol inhibits triglyceride and apolipoprotein B secretion in HepG2 cells.
    Casaschi A; Maiyoh GK; Rubio BK; Li RW; Adeli K; Theriault AG
    J Nutr; 2004 Jun; 134(6):1340-6. PubMed ID: 15173394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite effects of bezafibrate and gemfibrozil in both normal and hypertriglyceridemic rats.
    Krause BR; Barnett BC; Essenburg AD; Kieft KA; Auerbach BJ; Bousley R; Stanfield R; Newton RS; Bisgaier CL
    Atherosclerosis; 1996 Nov; 127(1):91-101. PubMed ID: 9006809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of gemfibrozil on triacylglycerol synthesis and secretion by liver and lipoprotein lipase activity in adipose tissue of rats.
    Nagao K; Sakono M; Nakayama M; Hirakawa T; Imaizumi K
    Comp Biochem Physiol B Biochem Mol Biol; 1999 Nov; 124(3):289-94. PubMed ID: 10631806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased intracellular degradation and increased secretion of apo B-100 in Hep G2 cells after inhibition of cholesteryl ester synthesis.
    Ooyen C; Zecca A; Zanelli T; Catapano AL
    Atherosclerosis; 1997 Apr; 130(1-2):143-52. PubMed ID: 9126658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of apolipoprotein B secretion from HepG2 cells by glucosyl hesperidin.
    Miwa Y; Mitsuzumi H; Yamada M; Arai N; Tanabe F; Okada K; Kubota M; Chaen H; Sunayama T; Kibata M
    J Nutr Sci Vitaminol (Tokyo); 2006 Jun; 52(3):223-31. PubMed ID: 16967768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of gemfibrozil and ketoconazole on human apolipoprotein AI, B and E levels in two hepatoma cell lines, HepG2 and Hep3B.
    Tam SP
    Atherosclerosis; 1991 Nov; 91(1-2):51-61. PubMed ID: 1811554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged inhibition of cholesterol synthesis by atorvastatin inhibits apo B-100 and triglyceride secretion from HepG2 cells.
    Funatsu T; Suzuki K; Goto M; Arai Y; Kakuta H; Tanaka H; Yasuda S; Ida M; Nishijima S; Miyata K
    Atherosclerosis; 2001 Jul; 157(1):107-15. PubMed ID: 11427209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal apolipoprotein B secretion is inhibited by the flavonoid quercetin: potential role of microsomal triglyceride transfer protein and diacylglycerol acyltransferase.
    Casaschi A; Wang Q; Dang K; Richards A; Theriault A
    Lipids; 2002 Jul; 37(7):647-52. PubMed ID: 12216835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell culture conditions determine apolipoprotein CIII secretion and regulation by fibrates in human hepatoma HepG2 cells.
    Clavey V; Copin C; Mariotte MC; Baugé E; Chinetti G; Fruchart J; Fruchart JC; Dallongeville J; Staels B
    Cell Physiol Biochem; 1999; 9(3):139-49. PubMed ID: 10494028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidylcholine increases apolipoprotein B secretion by enhancing lipid synthesis and decreasing its intracellular degradation in HepG2 cells.
    Zhou Z; Luchoomun J; Bakillah A; Hussain MM
    Biochim Biophys Acta; 1998 Mar; 1391(1):13-24. PubMed ID: 9518534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar to oleic acid, eicosapentaenoic acid stimulates apolipoprotein B secretion by inhibiting its intracellular degradation in Hep G2 cells.
    Kurokawa M; Hirano T; Furukawa S; Nagano S; Adachi M
    Atherosclerosis; 1995 Jan; 112(1):59-68. PubMed ID: 7772067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly.
    Tsai J; Qiu W; Kohen-Avramoglu R; Adeli K
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):211-8. PubMed ID: 17038630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of fenofibrate or simvastatin treatment of rats on hepatic microsomal overt and latent diacylglycerol acyltransferase activities.
    Waterman IJ; Zammit VA
    Diabetes; 2002 Jun; 51(6):1708-13. PubMed ID: 12031956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of Hep G2-cell triacylglycerol and apolipoprotein B synthesis and secretion by polyunsaturated non-esterified fatty acids and insulin.
    Byrne CD; Wang TW; Hales CN
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):101-7. PubMed ID: 1332692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein(a) synthesis and secretion from hepatoma cells is coupled to triglyceride synthesis and secretion.
    Nassir F; Bonen DK; Davidson NO
    J Biol Chem; 1998 Jul; 273(28):17793-800. PubMed ID: 9651381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells.
    Ganji SH; Tavintharan S; Zhu D; Xing Y; Kamanna VS; Kashyap ML
    J Lipid Res; 2004 Oct; 45(10):1835-45. PubMed ID: 15258194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.